Novamind to Discuss the Role of Ketamine in Eating Disorder Treatment at Leading Psychiatry Conference
Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this...
Year: 2020
Therma Bright Creates New Venture, Torion Biosciences to Develop its COVID-19 Rapid Antigen Test, CoviSafe(TM)
Therma Bright Investigates Spinoff of its Consumer Products Toronto, Ontario--(Newsfile Corp. - November 4, 2020) - Therma Bright Inc. (TSXV:...
Inogen Announces Third Quarter 2020 Financial Results
– Q3 2020 Total Revenue of $74.3 million – GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering...
Hologic Announces Financial Results for Fourth Quarter of Fiscal 2020
— Revenue of $1.347 Billion Increases 55.6%, 54.2% in Constant Currency — — Organic Revenue Increases 72.5%, 70.9% in Constant...
Vapotherm Reports Third Quarter 2020 Financial Results
Third Quarter 2020 Revenue of $30.6 Million Reflects 182.7% Increase Over Prior Year EXETER, N.H.--(BUSINESS WIRE)--Vapotherm, Inc. (NYSE: VAPO), (“Vapotherm”...
Axonics® Reports Third Quarter 2020 Results
Axonics generated net revenue of $35.2 million in the third quarter ended September 30, 2020 Over 5,500 patients have been...
Innovaccer’s Member Engagement Solution is Now Available on Microsoft Azure to Assist Payers Accelerate Their Digital Transformation Journey
SAN FRANCISCO, Nov. 4, 2020 /PRNewswire/ -- Innovaccer, Inc., a leading healthcare technology company, recently announced that their member engagement solution is...
Coastal Health USA Launches Infection Control Management Solution Specifically for the Education Staff and Students
SAN DIEGO, Nov. 4, 2020 /PRNewswire/ -- Coastal Health USA announced a powerful, first-of-its-kind solution that enables educational institutions to develop...
Services PMI™ at 56.6%; October 2020 Services ISM® Report On Business®
Business Activity Index at 61.2%; New Orders Index at 58.8%; Employment Index at 50.1%; Supplier Deliveries Index at 56.2% TEMPE,...
TransMedics Reports Third Quarter 2020 Financial Results
ANDOVER, Mass., Nov. 4, 2020 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming...
Avantor® Announces Secondary Offering of 71,339,001 Shares of Common Stock
RADNOR, Pa., Nov. 4, 2020 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR) ("Avantor" or the "Company"), a leading global provider of mission-critical...
Evogene Announces Closing of $12 Million Registered Direct Offering
REHOVOT, Israel, Nov. 4, 2020 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN), (TASE: EVGN), a leading computational biology company focused on revolutionizing product...
Medical Devices to Revolutionize with the Integration of Cloud, IoT and AI for Improved Patient Outcomes
Personalized, non-invasive, lightweight, and portable therapeutic medical devices are an emerging growth market trend, finds Frost & Sullivan SANTA CLARA,...
DarioHealth to Report Financial Results for the Third Quarter 2020 on November 12
NEW YORK, Nov. 4, 2020 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or the "Company"), a pioneer in the global digital...
2020 Technology and Health Trend Report
DUBLIN, Nov. 4, 2020 /PRNewswire/ -- The "Technology and Health Trend Report 2020" report has been added to ResearchAndMarkets.com's offering....
Fertibank at the Forefront of Genetic Studies Thanks to Agreement with Igenomix
BARCELONA, Spain, Nov. 4, 2020 /PRNewswire/ -- Fertibank egg and sperm bank has reached an agreement with the leading reproductive...
XPhyto Appoints European Healthcare Executive to Board of Directors
Experienced pharma executive and consultant Per S. Thoresen joins board Advisory engagement with CorpCann AS strengthens Europe-focused strategy VANCOUVER, BC...
MorphoSys to Present Data on Tafasitamab at the ASH Virtual Annual Meeting and Exposition
PLANEGG/MUNICH, GERMANY / ACCESSWIRE / November 4, 2020 / MorphoSys AG (FSE:MOR) Prime Standard Segment; MDAX & TecDAX; (NASDAQ:MOR) today...
Invitation to MorphoSys’ Third Quarter and First 9-Month 2020 Results Conference Call on November 12, 2020
PLANEGG/MUNICH, GERMANY / ACCESSWIRE / November 4, 2020 / MorphoSys AG (FSE:MOR; Prime Standard Segment, MDAX & TecDAX; NASDAQ:MOR) will...
Kadmon to Present 12-Month Data from Pivotal Trial of Belumosudil for cGVHD at the 62nd ASH Annual Meeting
NEW YORK, NY / ACCESSWIRE / November 4, 2020 / Kadmon Holdings, Inc. (NASDAQ:KDMN) announced today that 12-month data from...